Candiolo Cancer Institute - IRCCS

The Candiolo Cancer Institute is a private non-profit institution founded and supported by the Fondazione Piemontese per la Ricerca sul Cancro-Onlus (FPRC) and operated by the Fondazione del Piemonte per l’Oncologia (FPO: co-founded by FPRC and the Regione Piemonte). The Institute is a recognized IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) by the Italian Ministry of Health. The Candiolo Cancer Institute works in synergy with the University of Torino Medical School. Its mission is a significant contribution to fight cancer, by understanding the basics, and by providing state-of-the-art diagnostic and therapeutic services. The interface between molecular biology and medice is at the core of the Institute. FPRC provides enduring fund raising to complete and develop the Institute’s buildings and technologies in order to foster research.

AIRC Special Program in Clinical Molecular Oncology

"Molecular Clinical Oncology" is a novel discipline translating biology into medicine. Targeting single genetic lesions can interfere with tumor growth notwithstanding the multitude of genetic alterations harbored by cancers. This has given an unprecedented clinical value to the concept that cancer is a disease of genes, a dogma in molecular oncology that is now practically exploited by clinicians to set up novel classifications of tumors based on the presence of defined genetic lesions. Thanks to these advances, the idea of giving a patient a drug tailored to the genetic makeup of the tumor is becoming commonplace.

Highlights

MET-driven resistance to dual EGFR and BRAF blockade may be...
MM-151 overcomes acquired resistance to cetuximab and...
The genomic landscape of response to EGFR blockade in...

Pages

Next Events

  • Neutral evolution in cancer: distinguishing functional from nonfunctional intra-tumour heterogeneity
    Dr. Andrea Sottoriva
    Monday, September 19, 2016 - 14:00
    Location: Cappa Lecture Hall
    Download Poster: Sottoriva_September2016.pdf
  • Evidence that vessel co-option mediates resistance to anti-angiogenic therapy in cancer
    Dr. Andrew R. Reynolds
    Friday, September 23, 2016 - 14:00
    Location: Cappa Lecture Hall
    Download Poster: Reynolds_September2016.pdf
  • Mechanisms regulating tumor heterogeneity
    Prof. Cedric Blanpain
    Friday, October 21, 2016 - 14:00
    Location: Aula Cappa
    Download Poster: Blanpain_October2016.pdf
  • Clinical implications of the intrinsic molecular subtypes of breast cancer
    Dr. Aleix Prat
    Thursday, November 10, 2016 - 14:00
    Location: Cappa Lecture Hall
    Download Poster: Prat_November2016.pdf

Contacts

Istituto di Candiolo
Strada Provinciale, 142 km 3,95
10060 Candiolo, Torino-Italy

CENTRALINO
011-9933.111

How to reach the Institute

Visualizza IRCC in una mappa di dimensioni maggiori

Support Us